GSK CONSUMER: Lower adspends lead to significant margin beat (SKB IN, Mkt Cap USD4.4b, CMP INR7449, TP INR7670, 3% Upside, Neutral) Sales grew 7.9% YoY to INR11.9b (v/s est. of INR11.9b). Overall HFD volume grew 5.4% YoY with domestic HFD volume growth at 4% YoY. EBITDA grew 21.8% YoY to INR2.8b (v/s est. of INR2.4b); adj. PAT grew 36.1% YoY to INR2.4b (v/s est. of INR1.9b). Value market share (MAT Jun'19) for Horlicks stood at 44.3% (up 10bp YoY/ 140bp QoQ) while for Boost, it stood at...
GlaxoSmithKline Consumer Healthcare Ltd will continue to focus on brand extensions by introducing products and variants from its international portfolio as well as products derived from its research and development activities. Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profile...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.